We report the case of a 47-year-old man with hypertrophic obstructive cardiomyopathy who underwent transcoronary ablation of septal hypertrophy and developed severe aortic regurgitation after the procedure. Intra-operatively, we found a wide perforation of the noncoronary cusp, and performed aortic valve replacement.
MaronBJMcKennaWJDanielsonGKKappenbergerLJKuhnHJSeidmanCE. American College of Cardiology/European Society of Cardiology Clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J2003; 24: 1965–1991.
2.
SchulteHDBorisovKGamsEGramsch-ZabelHLoesseBSchwartzkopffB. Management of symptomatic hypertrophic obstructive cardiomyopathy—long-term results after surgical therapy. Thorac Cardiovasc Surg1999; 47: 213–218.
3.
GietzenFHLeunerCJRaute-KreinsenUDellmannAHegselmannJStrunk-MuellerC. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH): catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J1999; 20: 1342–1354.
4.
SathyamurthyI. Transcoronary ablation of septal hypertrophy (TASH). Indian Heart J2006; 58: 371–374.
UssiaGPSarkarKTamburinoC. Aortic valve perforation during aortic valvuloplasty: identification and strategies for prevention. Catheter Cardiovasc Interv2011; 77: 876–880.
8.
VogelMRigbyMLShoreD. Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrella. Pediatr Cardiol1996; 17: 416–418.
